act-541468
Showing 1 - 12 of 12
Renal Insufficiency, Healthy Trial in München (ACT-541468)
Completed
- Renal Insufficiency
- Healthy
- ACT-541468
-
München, GermanyAPEX GmbH
Sep 2, 2020
Obstructive Sleep Apnea Trial in Berlin (ACT-541468, Placebo)
Completed
- Obstructive Sleep Apnea
- ACT-541468
- Placebo
-
Berlin, GermanyAdvanced Sleep Research
Dec 18, 2019
Healthy Trial in Leiden (ACT-541468, Zopiclone 7.5 mg, Placebo)
Completed
- Healthy
- ACT-541468
- +2 more
-
Leiden, NetherlandsCentre for Human Drug Research
Oct 30, 2019
COPD Trial in Germany (ACT-541468, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- ACT-541468
- Placebo
-
Berlin, Germany
- +4 more
Sep 20, 2019
Healthy Recreational Drug Users Trial in Overland Park, Montreal (ACT-541468, Suvorexant, Zolpidem)
Completed
- Healthy Recreational Drug Users
- ACT-541468
- +3 more
-
Overland Park, Kansas
- +1 more
Sep 18, 2019
Healthy Trial in Pilsen (ACT-541468)
Completed
- Healthy
- ACT-541468
-
Pilsen, CzechiaCEPHA s.r.o.
Apr 10, 2019
Healthy Trial in Leiden (ACT-541468, ACT-541468 , Ethanol 10%)
Completed
- Healthy
- ACT-541468
- +3 more
-
Leiden, NetherlandsCentre For Human Drug Research
Oct 12, 2018
Healthy Subjects Trial in Leiden (ACT-541468, )
Completed
- Healthy Subjects
- ACT-541468
- placebo
-
Leiden, NetherlandsCentre for Human Drug Research
Jul 6, 2018
Healthy Subjects Trial in Kiel (ACT-541468, Diltiazem)
Completed
- Healthy Subjects
- ACT-541468
- Diltiazem
-
Kiel, GermanyCRS Clinical Research Services Kiel GmbH
Jul 6, 2018